Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment
Lin-Wen Wu,1,2,* Jian-Kang Zhang,1,2,* Mingjun Rao,3 Zuo-Yan Zhang,1,2 Hua-Jian Zhu,1,2 Chong Zhang1,21School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, People’s Republic of China; 2College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 3...
Main Authors: | Wu LW, Zhang JK, Rao M, Zhang ZY, Zhu HJ, Zhang C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-06-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/harmine-suppresses-the-proliferation-of-pancreatic-cancer-cells-and-se-peer-reviewed-article-OTT |
Similar Items
-
The inhibitory effects of compound Muniziqi granule against B16 cells and harmine induced autophagy and apoptosis by inhibiting Akt/mTOR pathway
by: Nan Zou, et al.
Published: (2017-12-01) -
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
by: Daniela Massihnia, et al.
Published: (2017-01-01) -
The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy
by: Jalal Baig, et al.
Published: (2019-07-01) -
Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01) -
Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma
by: Gong DJ, et al.
Published: (2013-07-01)